Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves

References

• Vural K M, Ozatik M A, Uncu H, Emir M, Yurdagok O, Sener E, Tasdemir O. Pregnancy after mechanical mitral valve replacement. J Heart Valve Dis 2003; 12: 370–376
   Google Scholar
• Larrea J L, Nunez L, Reque J A, Gil Aguado M, Matarros R, Minguez J A. Pregnancy and mechanical valve prostheses: A high-risk situation for the mother and the fetus. Ann Thorac Surg 1983; 36: 459–463
   PubMed Web of Science ®Google Scholar
• Born D, Martinez E E, Almeida P A, Santos D V, Carvalho A C, Moron A F, Miyasaki C H, Moraes S D, Ambrose J A. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992; 124: 413–417
   PubMedGoogle Scholar
• Sahnoun-Trabelsi I, Jimenez M, Choussat A, Roudaut R. [Prosthetic valve thrombosis in pregnancy. A single-center study of 12 cases]. Arch Mal Coeur Vaiss 2004; 97: 305–310
   PubMedGoogle Scholar
• Sbarouni E, Oakley C M. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196–201
   PubMedGoogle Scholar
• Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996; 27: 1698–1703
   PubMed Web of Science ®Google Scholar
• Iturbe-Alessio I, Fonseca M C, Mutchinik O, Santos M A, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986; 315: 1390–1393
   PubMed Web of Science ®Google Scholar
• Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000; 107: 245–253
   PubMed Web of Science ®Google Scholar
• Hanania G, Thomas D, Michel P L, Garbarz E, Age C, Millaire A, Acar J. Pregnancy and prosthetic heart valves: A French cooperative retrospective study of 155 cases. Eur Heart J 1994; 15: 1651–1658
   PubMed Web of Science ®Google Scholar
• Chan W S, Anand S, Ginsberg J S. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000; 160: 191–196
   PubMedGoogle Scholar
• Schaefer C, Hannemann D, Meister R, Elefant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006; 95: 949–957
   PubMed Web of Science ®Google Scholar
• Nassar A H, Hobeika E M, Abd Essamad H M, Taher A, Khalil A M, Usta I M. Pregnancy outcome in women with prosthetic heart valves. Am J Obstet Gynecol 2004; 191: 1009–1013
   PubMedGoogle Scholar
• Blickstein D, Blickstein I. The risk of fetal loss associated with warfarin anticoagulation. Int J Gynaecol Obstet 2002; 78: 221–225
   PubMed Web of Science ®Google Scholar
• Cotrufo M, De Feo M, De Santo L S, Romano G, Della Corte A, Renzulli A, Gallo C. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 2002; 99: 35–40
   PubMed Web of Science ®Google Scholar
• Srivastava A K, Gupta A K, Singh A V, Husain T. Effect of oral anticoagulant during pregnancy with prosthetic heart valve. Asian Cardiovasc Thorac Ann 2002; 10: 306–309
   Google Scholar
• Meschengieser S S, Fondevila C G, Santarelli M T, Lazzari M A. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999; 82: 23–26
   Google Scholar
• Chen W W, Chan C S, Lee P K, Wang R Y, Wong V C. Pregnancy in patients with prosthetic heart valves: An experience with 45 pregnancies. QJM 1982; 51: 358–365
   Google Scholar
• Wesseling J, Van Driel D, Heymans H S, Rosendaal F R, Geven-Boere L M, Smrkovsky M, Touwen B C, Sauer P J, Van der Veer E. Coumarins during pregnancy: Long-term effects on growth and development of school-age children. Thromb Haemost 2001; 85: 609–613
   PubMed Web of Science ®Google Scholar
• Bates S M, Greer I A, Hirsh J, Ginsberg J S. Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl)S627–644
   Google Scholar
• Lee L H, Liauw P C, Ng A S. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996; 76: 628–630
   PubMed Web of Science ®Google Scholar
• Ginsberg J S, Chan W S, Bates S M, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003; 163: 694–698
   PubMedGoogle Scholar
• Lovenox (enoxaparin sodium injection). Aventis Pharmaceuticals, Available at: http://products.sanofi-aventis.us/lovenox/lovenox.html#Boxed%20warning
   Google Scholar
• Leyh R T, Fischer S, Ruhparwar A, Haverich A. Anticoagulant therapy in pregnant women with mechanical heart valves. Arch Gynecol Obstet 2003; 268: 1–4
   Google Scholar
• Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004; 92: 747–751
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion: Safety of Lovenox in pregnancy. Obstet Gynecol 2002; 100: 845–846
   Google Scholar
• Rowan J A, McCowan L M, Raudkivi P J, North R A. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001; 185: 633–637
   PubMed Web of Science ®Google Scholar
• Weitz J I. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688–698
   PubMed Web of Science ®Google Scholar
• Czestochowska E. [Thromboembolism prophylaxis in pregnancy and labor]. Ginekol Pol 1996; 67: 548–551
   Google Scholar
• Harenberg J, Huhle G, Piazolo L, Giese C, Heene D L. Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin. Semin Thromb Hemost 1997; 23: 167–172
   PubMedGoogle Scholar
• Tenconi P, Gatti L, Acacia B. Low molecular weight heparin in pregnant women with mechanical valve prosthesis—case report. Thromb Haemost 1997; 78: PS-2996
   Google Scholar
• Arnaout M S, Kazma H, Khalil A, Shasha N, Nasrallah A, Karam K, Alam S E. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?. Clin Exp Obstet Gynecol 1998; 25: 101–104
   PubMedGoogle Scholar
• Abildgaard U, Gjestvang F T, Lossius P, Hodne E. [Low molecular heparin in a pregnant women with heart valve prosthesis]. Tidsskr Nor Laegeforen 1999; 119: 4319–4320
   Google Scholar
• Seshadri N, Goldhaber S Z, Elkayam U, Grimm R A, Groce J B, 3rd, Heit J A, Spinler S A, Turpie A G, Bosker G, Klein A L. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 2005; 150: 27–34
   PubMed Web of Science ®Google Scholar
• Berndt N, Khan I, Gallo R. A complication in anticoagulation using low-molecular weight heparin in a patient with a mechanical valve prosthesis. A case report. J Heart Valve Dis 2000; 9: 844–846
   Google Scholar
• Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: Treatment failure. Ann Thorac Surg 2000; 69: 264–265, discussion 265–266
   PubMed Web of Science ®Google Scholar
• Roberts N, Ross D, Flint S K, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. BJOG 2001; 108: 327–329
   Google Scholar
• Oles D, Berryessa R, Campbell K, Bhatti M A. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: A case report. Perfusion 2001; 16: 159–164
   Google Scholar
• Ellison J, Thomson A J, Walker I D, Greer I A. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. BJOG 2001; 108: 757–759
   Google Scholar
• Leyh R G, Fischer S, Ruhparwar A, Haverich A. [Anticoagulation in pregnant women after artificial heart valve replacement: Is low-molecular-weight heparin an alternative?]. Z Kardiol 2002; 91: 297–303
   Google Scholar
• Behrendt P, Schwartzkopff B, Perings S, Gerhardt A, Zotz R B, Strauer B E. Successful thrombolysis of St. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: A case report. Cardiol Rev 2002; 10: 349–353
   PubMedGoogle Scholar
• Meschengieser S, Salviu M, Sanchez Luceros A S, Casais P, Hendler M F, Turdo K, Lazzari M A. Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV). J Thromb Haemost 2003; 1(Suppl 1)P1479
   Google Scholar
• Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med 2003; 163: 2788–2789
   Google Scholar
• Usta I M, Abdallah M, El-Hajj M, Nassar A H. Massive subchorionic hematomas following thrombolytic therapy in pregnancy. Obstet Gynecol 2004; 103: 1079–1082
   PubMed Web of Science ®Google Scholar
• Obergfell A, Langenfeld H, Hopp H, Steigerwald U, Grossmann R. Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin. Thromb Haemost 2004; 91: 839–840
   PubMed Web of Science ®Google Scholar
• Lavoie J P, Leduc L, Mercier L A. Embolic myocardial infarction in a pregnant woman with a mechanical heart valve on low molecular weight heparin. Can J Cardiol 2004; 20: 917–919
   Google Scholar
• Inyang A N, Jackson M, Kumar A, Nychka A, Leyvi G, Zhuravlev I, Plestis K, Wasnick J. A report of a case: Anesthetic management of a parturient with severe thrombotic stenosis of a mechanical aortic valve—an exercise in coordination of subspecialties. Semin Cardiothorac Vasc Anesth 2005; 9: 261–263
   Google Scholar